Jane B Trepel - National Cancer Institute

Jane B Trepel

National Cancer Institute

United States

Jane B Trepel - National Cancer Institute

Jane B Trepel

Introduction

Primary Affiliation: National Cancer Institute - United States

Publications

73Publications

2292Reads

-Profile Views

1365PubMed Central Citations

Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.

Leuk Lymphoma 2017 04 11;58(4):923-931. Epub 2016 Aug 11.

a Laboratory of Infectious Diseases , National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1213823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358278PMC
April 2017
29 Reads
1 Citation

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.

Clin Genitourin Cancer 2017 02 27;15(1):77-85. Epub 2016 May 27.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583922PMC
February 2017
160 Reads
7 Citations
1.693 Impact Factor

The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat.

Oncoimmunology 2016 31;5(11):e1219008. Epub 2016 Aug 31.

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1219008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139687PMC
August 2016
53 Reads
7 Citations
6.283 Impact Factor

Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells.

J Urol 2016 Apr 12;195(4 Pt 1):1136-42. Epub 2015 Nov 12.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.11.013DOI Listing
April 2016
32 Reads
2 Citations
4.471 Impact Factor

Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies.

Cancer Res 2016 Feb 2;76(4):902-11. Epub 2016 Feb 2.

Developmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1617DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827779PMC
February 2016
29 Reads
13 Citations
9.330 Impact Factor

Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors.

Cell Rep 2016 Feb 21;14(4):872-884. Epub 2016 Jan 21.

Department of Urology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA; Cancer Research Institute, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.12.084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887101PMC
February 2016
43 Reads
10 Citations
7.210 Impact Factor

Immunotherapies for bladder cancer: a new hope.

Curr Opin Urol 2015 Nov;25(6):586-96

aGenitourinary Malignancies Branch bDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA cDepartment of Urology, Medical University of Vienna, Vienna, Austria dCancer Research Unit, Warwick University Medical School, Coventry, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000213DOI Listing
November 2015
25 Reads
3 Citations
2.333 Impact Factor

c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells.

Cell Rep 2015 Aug 30;12(6):1006-18. Epub 2015 Jul 30.

Department of Urology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA; Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA; Cancer Research Institute, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778718PMC
August 2015
108 Reads
14 Citations
7.210 Impact Factor

Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer.

J Transl Med 2015 Jul 22;13:239. Epub 2015 Jul 22.

Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, 10 Center Dr. MSC1906, Building 10, Room 12N/226, Bethesda, MD, 20892-1906, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-015-0604-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508767PMC
July 2015
21 Reads
4 Citations
3.930 Impact Factor

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

Lancet Oncol 2015 Feb 13;16(2):177-86. Epub 2015 Jan 13.

Division of Hematology/Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)71181-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401497PMC
February 2015
39 Reads
20 Citations
24.690 Impact Factor

Stressing the development of small molecules targeting HSP90.

Clin Cancer Res 2014 Jan 28;20(2):275-7. Epub 2013 Oct 28.

Authors' Affiliations: Urologic Oncology Branch and Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2571DOI Listing
January 2014
9 Reads
16 Citations
8.722 Impact Factor

The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models.

Cancer Res 2013 Dec 11;73(23):7022-33. Epub 2013 Oct 11.

Authors' Affiliations: Urologic Oncology Branch and Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; Departments of Urology, Biochemistry, and Molecular Biology, Cancer Research Institute, SUNY Upstate Medical University, Syracuse, New York; and Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1156DOI Listing
December 2013
5 Reads
20 Citations
9.330 Impact Factor

Synthesis and structure-activity relationship studies of novel dihydropyridones as androgen receptor modulators.

J Med Chem 2013 Nov 30;56(21):8280-97. Epub 2013 Oct 30.

Laboratory of Synthetic Chemistry, Frederick National Laboratory for Cancer Research, SAIC Frederick, Inc. , Frederick, Maryland 21702, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm301714sDOI Listing
November 2013
19 Reads
3 Citations
5.450 Impact Factor

Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma.

PLoS One 2013 14;8(2):e56083. Epub 2013 Feb 14.

Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0056083PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573066PMC
August 2013
4 Reads
9 Citations
3.234 Impact Factor

Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity.

Future Med Chem 2013 Jun;5(9):1059-71

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-1107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc.13.88DOI Listing
June 2013
11 Reads
24 Citations
4.000 Impact Factor

Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation.

Blood 2013 Jun 9;121(25):5045-54. Epub 2013 May 9.

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Center for Viral Oncology, Kansas City, KS 66160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-07-439109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689251PMC
June 2013
26 Reads
10 Citations
10.452 Impact Factor

Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality.

Cancer Cell 2013 Feb 23;23(2):228-37. Epub 2013 Jan 23.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2012.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574184PMC
February 2013
44 Reads
25 Citations
23.523 Impact Factor

Methoxychalcone inhibitors of androgen receptor translocation and function.

Bioorg Med Chem Lett 2012 Mar 21;22(5):2105-9. Epub 2012 Jan 21.

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2011.12.141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308679PMC
March 2012
8 Reads
2 Citations
2.420 Impact Factor

Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.

Proc Natl Acad Sci U S A 2011 Jul 5;108(29):11878-83. Epub 2011 Jul 5.

Department of Biological Sciences and Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1105160108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141981PMC
July 2011
41 Reads
36 Citations
9.810 Impact Factor

STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer.

Curr Opin Investig Drugs 2010 Dec;11(12):1466-76

Center for Cancer Research, Medical Oncology Branch & Urologic Oncology Branch, National Cancer Institute/NIH, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
December 2010
49 Reads
36 Citations

Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.

J Biol Chem 2009 May 18;284(22):15206-14. Epub 2009 Mar 18.

Laboratory of Cancer Biology and Genetics, Medical Oncology Branch, Pediatric Oncology Branch, and Urologic Oncology Branch, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M806324200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685701PMC
May 2009
20 Reads
21 Citations
4.573 Impact Factor

Histone deacetylase inhibitors in cancer therapy.

Curr Opin Oncol 2008 Nov;20(6):639-49

Medical Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3283127095DOI Listing
November 2008
22 Reads
33 Citations
4.470 Impact Factor

Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer.

Cancer Biol Ther 2008 Sep 2;7(9):1388-97. Epub 2008 Sep 2.

Department of Pathology, Institute of Basic Medical Sciences, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.7.9.6415DOI Listing
September 2008
20 Reads
16 Citations
3.072 Impact Factor

Pharmacodynamic assessment of histone deacetylase inhibitors: infrared vibrational spectroscopic imaging of protein acetylation.

Anal Chem 2008 Aug 24;80(16):6390-6. Epub 2008 Jul 24.

Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ac800840yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684873PMC
August 2008
21 Reads
2 Citations
5.640 Impact Factor

KIT regulates tyrosine phosphorylation and nuclear localization of beta-catenin in mast cell leukemia.

Leuk Res 2008 May 18;32(5):761-70. Epub 2007 Oct 18.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1107, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.08.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682210PMC
May 2008
7 Reads
7 Citations
2.351 Impact Factor

Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection.

J Immunol 2008 Jan;180(1):89-105

Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.1.89DOI Listing
January 2008
20 Reads
17 Citations
4.922 Impact Factor

Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist.

Cancer Res 2007 Jul;67(13):6012-6

Urologic Oncology Branch, Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892-1107, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/67/13/6012.full.pd
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-07-0022DOI Listing
July 2007
36 Reads
20 Citations
9.330 Impact Factor

PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control cAMP response element-dependent transcription in response to nerve growth factor and cAMP.

J Neurochem 2006 Dec 24;99(6):1517-30. Epub 2006 Oct 24.

Cellular and Molecular Pathology Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-4159.2006.04196.xDOI Listing
December 2006
21 Reads
4 Citations
4.281 Impact Factor

Histone deacetylase inhibitors induce apoptosis with minimal viral reactivation in cells infected with Kaposi's sarcoma-associated herpesvirus.

J Invest Dermatol 2006 Nov 29;126(11):2516-24. Epub 2006 Jun 29.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jid.5700438DOI Listing
November 2006
8 Reads
4 Citations
7.220 Impact Factor

Assays for pharmacodynamic analysis of histone deacetylase inhibitors.

Expert Opin Drug Metab Toxicol 2006 Apr;2(2):213-30

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Medical Oncology Branch, Building 10, Room 12N230, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2.2.213 DOI Listing
April 2006
5 Reads
3 Citations
2.831 Impact Factor

Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometry.

Ann Clin Lab Sci 2005 ;35(4):397-406

Medical Oncology Clinical Research Unit, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.annclinlabsci.org/content/35/4/397.full.pdf
Web Search
February 2006
25 Reads
4 Citations
0.840 Impact Factor

Chromosomal protein HMGN1 modulates the expression of N-cadherin.

FEBS J 2005 Nov;272(22):5853-63

Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1742-4658.2005.04980.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730465PMC
November 2005
23 Reads
11 Citations
4.001 Impact Factor

A phase II study of perifosine in androgen independent prostate cancer.

Cancer Biol Ther 2005 Oct 1;4(10):1133-7. Epub 2005 Oct 1.

Medical Oncology Clinical Research Unit, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.4.10.2064DOI Listing
October 2005
9 Reads
20 Citations
3.072 Impact Factor

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma.

J Clin Oncol 2005 Jun 25;23(17):3912-22. Epub 2005 Apr 25.

Clinical Trials Unit, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.188DOI Listing
June 2005
37 Reads
86 Citations
18.430 Impact Factor

Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells.

Oncogene 2005 Mar;24(14):2386-97

Thoracic Oncology Section, Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208376DOI Listing
March 2005
29 Reads
5 Citations
8.460 Impact Factor

Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment.

Mol Cancer Ther 2004 Dec;3(12):1505-12

Department of Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007-2197, USA.

View Article

Download full-text PDF

Source
December 2004
5 Reads
17 Citations
5.683 Impact Factor

Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.

Mol Cancer Ther 2004 Jun;3(6):715-25

Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick, Building 322, Room 104, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
June 2004
22 Reads
17 Citations
5.683 Impact Factor

Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells.

Clin Cancer Res 2004 Mar;10(5):1813-25

Thoracic Oncology Section, Surgery Branch, and Medical Oncology Clinical Research Unit, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892-1502, USA.

View Article

Download full-text PDF

Source
March 2004
10 Reads
16 Citations
8.722 Impact Factor

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

Cancer Res 2004 Jan;64(1):316-21

Radiation Oncology Branch and Molecular Radiation Therapeutics Branch, Radiation Oncology Sciences Program, Medicine Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
January 2004
9 Reads
49 Citations
9.330 Impact Factor

Ion channels as molecular targets in prostate cancer.

Authors:
Jane B Trepel

Clin Prostate Cancer 2003 Dec;2(3):188-9

Medical Oncology Clinical Research Unit, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
December 2003
6 Reads
1 Citation

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.

Carcinogenesis 2003 Mar;24(3):453-9

Department of Anatomy and Biology, Osaka Medical College, 2-7, Daigaku-machi, Takatsuki, Osaka 569-8686, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/24.3.453DOI Listing
March 2003
19 Reads
19 Citations
5.334 Impact Factor

Anticancer-drug-induced apoptotic cell death in leukemia cells is associated with proteolysis of beta-catenin.

Leuk Res 2002 Sep;26(9):863-71

Department of Pathology, College of Oriental Medicine, Wonkwang University, Iksan, Chonbuk, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(02)00018-8DOI Listing
September 2002
3 Reads
4 Citations
2.351 Impact Factor

Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin.

Blood 2002 Aug;100(3):982-90

Medical Oncology Clinical Research Unit and Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v100.3.982DOI Listing
August 2002
10 Reads
44 Citations
10.452 Impact Factor

Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells.

J Biol Chem 2002 Feb 13;277(7):5168-74. Epub 2001 Dec 13.

Laboratory of Cell Regulation and Carcinogenesis, the Developmental Therapeutics Program, and the Medicine Branch, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M106451200DOI Listing
February 2002
8 Reads
18 Citations
4.573 Impact Factor

Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2.

Cell Stress Chaperones 2002 Jan;7(1):91-6

Department of Cell and Cancer Biology, Medicine Branch, National Cancer Institute, Rockville, MD 20850, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC514806PMC
http://dx.doi.org/10.1379/1466-1268(2002)007<0091:hngrti>2.0.co;2DOI Listing
January 2002
10 Reads
27 Citations
3.163 Impact Factor

Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.

Mol Pharmacol 2002 Jan;61(1):13-9

Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.61.1.13DOI Listing
January 2002
7 Reads
10 Citations
4.130 Impact Factor

Top co-authors

Min-Jung Lee
Min-Jung Lee

National Cancer Institute

38
Sunmin Lee
Sunmin Lee

National Cancer Institute

25
Len Neckers
Len Neckers

National Cancer Institute

18
William D Figg
William D Figg

National Cancer Institute

13
Yusuke Tomita
Yusuke Tomita

Kumamoto University

12
Seth M Steinberg
Seth M Steinberg

Center for Cancer Research

11
Mehdi Mollapour
Mehdi Mollapour

National Cancer Institute

10
Eun Joo Chung
Eun Joo Chung

Inje University College of Medicine

9
Shinji Tsutsumi
Shinji Tsutsumi

National Cancer Institute

8
Yeong Sang Kim
Yeong Sang Kim

National Cancer Institute

8